Moderate Systemic Contagious Viral Exanthems

Rubella (German Measles)

Usually mild contagious viral infection that is dangerous in pregnancy.

Primary risk age: Children and adolescents; rare where MMR vaccination is routine.

Urgency: Moderate
Typical age: Children and adolescents; rare where MMR vaccination is routine.
Body system: Infectious & Parasitic

Typical course: Symptoms typically resolve within 3–5 days.

Reviewed against AAP · CDC · WHO · NHS guidance Last reviewed 2026-06-13

1. Summary & Pathophysiology

Usually mild contagious viral infection that is dangerous in pregnancy.

Pathophysiology (Development Path)

The virus causes a mild systemic infection with a rash and swollen glands; in early pregnancy it can cross the placenta and cause serious birth defects (congenital rubella syndrome).

Primary Causes & Etiology

The rubella virus, spread by respiratory droplets; an infected pregnant woman can pass it to her unborn baby.

2. Symptom Continuum

Early Onset Signs
Low-grade fever, mild cold-like symptoms, and tender swollen glands behind the ears and at the back of the neck.
Progressive Phase
A fine pink rash that starts on the face and spreads down the body, fading after a few days; older children and adults may have joint aches.
Severe Indicators
Serious illness is uncommon in children; the main danger is infection of a pregnant woman, which threatens the unborn baby.

3. Clinical Verification

Clinical suspicion confirmed by blood or swab tests, which is important for public health and to protect pregnant contacts.

4. Care & Elements Plan

Primary Care Treatment Plan

No specific treatment; supportive care while the mild illness clears, with isolation to protect others — especially pregnant women.

Home Support Elements

Rest, fluids, and fever relief as needed. Keep the child away from others, particularly pregnant women, until no longer infectious.

Generic Active Ingredients (No Brands)

Acetaminophen/Paracetamol or ibuprofen (fever and discomfort)
supportive fluids and rest (drug-free care). There is no specific antiviral.

Lists active elements only. Never administer self-designed therapies.

5. Doctor Critical Lines

Critical Thresholds: When to See a Doctor

See a doctor to confirm the diagnosis and report the case, and urgently if a pregnant woman may have been exposed or if the child becomes seriously unwell.

6. Vaccine & Prevention

Routine Prophylaxis (Prevention)

The MMR vaccine prevents rubella and protects future pregnancies; high community vaccination protects unborn babies.

Immunization Context

Rubella is prevented by the MMR vaccine at 12–15 months and 4–6 years; vaccinating children also protects pregnant women in the community.

7. Timelines & Outlook

Active Timeline

Symptoms typically resolve within 3–5 days.

Expected Prognosis

Excellent in children, who usually recover within a few days; the serious risk is to the unborn baby of an infected pregnant woman.

Potential Untreated Complications

Rare in children (occasional joint or, very rarely, brain or bleeding problems); congenital rubella syndrome in babies of infected mothers is the major concern.

Severe

Measles (Rubeola)

Highly Contagious Paramyxoviral Exanthematous Disease

Unvaccinated infants, young children, and adolescents.

Moderate

Varicella Zoster (Chickenpox)

Acute Alphaherpesviral Vesicular Exanthematous Disease

Unvaccinated preschool and school-aged children.